63
3
25
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T35827 | Epsilon-V1-2 | PKCε Inhibitor Peptide,Protein Kinase Cɛ Inhibitor Peptide,ɛV1-2 | |
Protein kinase C (PKC ) is a calcium-independent, phospholipid- and diacylglycerol-dependent serine/threonine kinase involved in diverse signaling pathways, including those involved in neuronal signaling, cytoskeletal f... | |||
T124032 | V1 iridoid | ||
V1 iridoid is a useful organic compound for research related to life sciences and the catalog number is T124032. | |||
T80249 | Epsilon-V1-2, Cys-conjugated | PKC | |
Epsilon-V1-2, a Cys-conjugated, is a biologically active peptide known as the εPKC-specific inhibitor. It hampers εPKC functionality by obstructing its translocation and the phosphorylation of MARCKS, additionally pertur... | |||
T13920L | Terlipressin Acetate | Terlipressin diacetate anhydrous,Terlipressin acetate anhydrous | Vasopressin Receptor |
Terlipressin Acetate, a highly selective vasopressin V1 receptor agonist, on oxygen and glucose deprivation/re-oxygenation (OGD/R)-induced damage in intestinal epithelial cells (IEC-6).Terlipressin acetate exerts anti-in... | |||
T60016 | VV116 | GS-621763-d1,JT001 | SARS-CoV , RSV |
VV116 (JT001) is a selective and orally active nucleoside antiviral agent against respiratory syncytial virus (RSV) and SARS-CoV-2 infection. | |||
T8579 | Nav1.8-IN-1 | 5-(4-Chlorophenyl)-N-[[2-(2,2,2-trifluoroethoxy)pyridin-3-yl]methyl]pyridine-3-carboxamide,CHEMBL1270208 | Sodium Channel |
Nav1.8-IN-1 (CHEMBL1270208) is an inhibitor of human NaV1.8 | |||
T16967 | T-00127_HEV1 | PI4K | |
T-00127_HEV1 is an inhibitor of phosphatidylinositol 4-kinase III beta (IC50: 60 nM). | |||
T72170 | NaV1.2/1.6 channel blocker-1 | Sodium Channel | |
NaV1.2/1.6 channel blocker-1 is a potent NaV1.2/1.6 channel blocker with inhibitory effects on rNaV1.6 and hNaV1.2.NaV1.2 channel blocker-1 can be used in the study of generalised epilepsy and movement disorders. | |||
T16163 | MV1 | Apoptosis | |
MV1 is an antagonist of IAP. When combined with HaloTag ligand, MV1 causes protein knockdown of HaloTag-fused proteins. | |||
T40508L | TRV120056 acetate | TRV120056 acetate (40678-47-5 Free base) | Others |
TRV120056 acetate is a Gq-biased agonist with 10-fold greater molecular efficiency on AT1R-Gq fusion proteins than AT1R-βarr2 fusion proteins. | |||
T27503 | GV150013 | GV 150013,GV-150013 | cholecystokinin |
GV150013 is an antagonist of cholecystokinin-2 (CCK2) receptor. | |||
TP1554L | HPV16 E7 (86-93) acetate | HPV16 E7 (86-93) acetate(160212-93-1 Free base) | Others |
T77693 | Nav1.8-IN-4 | Sodium Channel | |
Nav1.8-IN-4 is a potent Nav1.8 channel inhibitor with potential analgesic activity.Nav1.8-IN-4 can be used for pain and neurological related disorders. | |||
T12181 | NaV1.7 inhibitor-1 | Sodium Channel | |
NaV1.7 inhibitor-1, an efficacious inhibitor of voltage-gated sodium channel (NaV) 1.7 (IC50 of 0.6 nM for hNaV1.7). | |||
T83701 | TRPV1-Tat TFA | Transient Receptor Potential Vanilloid 1-Tat,736-745-Tat | |
TRPV1-Tat, a peptide antagonist targeting transient receptor potential vanilloid 1 (TRPV1), is composed of amino acids 736-745 derived from TRPV1's A-kinase anchor protein (AKAP)-binding domain, combined with the HIV Tat... | |||
T12184 | Nav1.7 inhibitor | Others | |
Nav1.7 inhibitor is a potent inhibitor of Nav1.7. | |||
T12182 | Nav1.7-IN-2 | Others | |
Nav1.7-IN-2 is avoltage-gated sodium channels (Nav) inhibitor in particular Nav 1.7(IC50 of 80 nM). | |||
T38911 | Nav1.7-IN-8 | Nav1.7-IN-8 | |
Nav1.7-IN-8 is a highly potent and selective inhibitor of NaV1.7, exhibiting greater selectivity for inhibiting NaV1.7 compared to the subtypes hNaV1.1 and hNaV1.5. Additionally, Nav1.7-IN-8 has inhibitory effects on CYP... | |||
T60544 | HPV18-IN-1 | ||
HPV18-IN-1 (Compound H1) is a potent HPV18 inhibitor that prevents cervical cancer cells from premature cell procession and abnormal proliferation. HPV18-IN-1 supresses E7-Rb-E2F cellular pathway and DNA methylation with... | |||
T28132 | NaV1.7 Blocker-801 | ||
NaV1.7 Blocker-801 is a potent NaV1.7 blocker. | |||
T74741 | TRPV1 activator-1 | ||
TRPV1 Activator-1 (Compound 8), a capsaicin analog featuring a modified neck structure, specifically interacts with the T551 residue [1]. | |||
T61026 | CaV1.3 antagonist-1 | ||
CaV1.3 antagonist-1 is a cyclopentyl derivative with the potential for the research of Parkinson's disease. CaV1.3 antagonist-1 inhibits Ca V 1.3 LTCC over 600-fold more effectively than Ca V 1.2 LTCC. CaV1.3 antagonist-... | |||
T79445 | KV1.3-IN-1 | Potassium Channel | |
KV1.3-IN-1 (Compound trans-18), a selective KV1.3 channel inhibitor with IC50 values of 230 nM in Ltk cells and 26.12 nM in PHA-activated T-lymphocytes, disrupts intracellular Ca2+ signaling and impedes T-cell activation... | |||
T12183 | Nav1.7-IN-3 | Others | |
Nav1.7-IN-3 is a selective and orally bioavailable inhibitor of voltage-gated sodium channel Nav1.7(IC50 of 8 nM). | |||
T28840 | SPV106 | ||
SPV106 is a ligand of lysine acetyltransferases (KATs). | |||
T39995 | TRV120055 | TRV120055 | |
TRV120055, a Gq-biased agonist, demonstrates a 10-fold higher molecular efficacy when tested against the AT1R-Gq fusion protein in comparison to the AT1R-βarr2 fusion protein. | |||
TP1554 | HPV16 E7 (86-93) | ||
This is amino acids 86 to 93 fragment of the human papilloma virus (HPV) type 16 oncoprotein E7. This HPV16-encoded peptide has very high affinity of binding to the HLA-A*0201 molecule.This immunogenic fragment may be us... | |||
T40508 | TRV120056 | ||
TRV120056 is a Gq-biased agonist that demonstrates a molecular efficacy ten times greater at the AT1R-Gq fusion protein than at the AT1R-βarr2 fusion protein. | |||
T76015 | HPV16 E7 (86-93) (TFA) | ||
HPV16 E7 (86-93) TFA, a peptide derived from HPV16 E7, is restricted by human leukocyte antigen (HLA)-A2.1 and exhibits immunogenic properties in cervical carcinomas [1] [2]. | |||
T19696 | CV1808 | CV 1808,CV-1808 | |
CV-1808 is a coronary vasodilator, antihypertensive, and antipsychotic following systemic administration in vivo. CV-1808 is an adenosine A2 receptor agonist. | |||
T71716 | Nav1.1-IN-B | ||
Nav1.1-IN-B is a selective NaV1.1 inhibitor which reduces visceral hypersensitivity. | |||
T63339 | ALV1 | ||
ALV1 is a potent degradation agent of Ikaros and Helios, with similar degradation activity against IKZF1/2/3. ALV1 significantly reduced the protein abundance of IKZF1-4, CK1α (casein kinase 1α, CSNK1A1) and ribosomal pr... | |||
T126501 | Xanthone V1a | ||
Xanthone V1a is a useful organic compound for research related to life sciences and the catalog number is T126501. | |||
T12179 | Nav1.1 activator 1 | Others | |
Nav1.1 activator 1 is a highly potent activator of Nav1.1 with BBB penetration. | |||
T62422 | Nav1.8-IN-2 | ||
Nav1.8-IN-2 (compound 35A) is a potent inhibitor of Nav1.8 (IC50: 0.4 nM). Nav1.8-IN-2 can be used in studies of pain disorders, cough, acute and chronic pruritus. | |||
T68275 | MV151 | ||
MV151 is a fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo. MV151 specifically targets all active subunits of the proteasome and immunoproteasome in living cells, allowing fo... | |||
T29084 | V116517 | V-116517,V 116517 | |
V-116517, a TRPV1 antagonist, is used potentially for the treatment of severe pain due to osteoarthritis and chronic pain due postherpetic neuralgia (PHN). | |||
T27757 | Kv1.5-IN-IIII | Kv1.5INIIII,Kv1.5INIV,Compound IIII,Kv1.5IN4,Compound 4 | |
Kv1.5-IN-IIII is a potent inhibitor of Kv1.5. | |||
T80160 | ω-Hexatoxin-Hv1a | ω-ACTX-Hv1,ω-Atracotoxin-HV1 | Calcium Channel |
ω-Hexatoxin-Hv1a, a neurotoxin extracted from the venom of the spider Hadronyche versuta, inhibits voltage-gated calcium channels [1] [2]. | |||
T61788 | TRPV1 antagonist 3 | ||
TRPV1 antagonist 3 (Compound 7q) is a highly potent antagonist of the TRPV1 receptor with an IC50 of 2.66 nM against capsaicin. It exhibits selectivity towards its mode of action and is orally bioavailable (with a bioava... | |||
T70362 | V11294A | ||
V11294A is a novel PDE4 inhibitor. A single oral 300 mg dose of V11294A administered to healthy volunteers results in plasma concentrations adequate to inhibit activation of inflammatory cells ex vivo, which persists fo... | |||
T61110 | UC-1V150 | ||
UC-1V150 is a distinct TLR7 agonist, which activates cellular immune responses and exhibits anti-tumor effects. It also serves as a precursor for the synthesis of ISAC molecules, known as immune-stimulating antibody conj... | |||
T74742 | TRPV1 activator-2 | ||
TRPV1 activator-2 (Compound 9), a capsaicin head analog, engages in targeted interactions with channel residues at the lipid-water interface [1]. | |||
T12180 | Nav1.7-IN-6 | Others | |
Nav1.7-IN-6, a selective inhibitor of Nav1.7. | |||
TP1515 | HPV16-E711-20 epitope | ||
HPV16-E711-20 epitope is a well-known HLA-A*0201-restricted human cytotoxic T lymphocyte (CTL) epitope of the HPV16 E7 protein that shows high-affinity binding to HLA-A2 in vitro. | |||
T60316 | AV123 | ||
AV123 (compound 12) is a non-cytotoxic RIPK1 inhibitor with IC 50 of 12.12 μM. AV123 blocks the TNF-α-induced necroptotic with EC 50 of 1.7 μM, but not the apoptotic cell death. AV123 can be used in the study of necrotic... | |||
T79280 | Nav1.3 channel inhibitor 1 | Sodium Channel | |
Nav1.3 Channel Inhibitor 1 (Compound 15b) is a state-dependent inhibitor of the voltage-gated sodium channel Na v 1.3, with an IC50 value of 20 nM. It has the ability to cross the blood-brain barrier, making it applicabl... | |||
T31537 | DIV17E5 | DIV17-E5,DIV17 E5,DIV-17E5,DIV 17E5 | |
DIV17E5 is a biochemical. | |||
TP1525 | HPV16 E7 (86-93) (TFA)(160212-93-1,free) | HPV16 E7 (86-93) (TFA) | |
HPV16 E7 (86-93) TFA is a human leukocyte antigen (HLA)-A2.1 restricted HPV16 E7-derived peptide. | |||
T23818 | BPU-11 | Biphenyl Urea 11 | Others |
BPU-11 (Biphenyl Urea 11) is an HCN4 CLP ligand that acts by modulating channel function and completely abolishing the cAMP-induced shift in V1/2. |
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T2S2215 | Crebanine | Apoptosis , Others , Akt | |
1. Crebanine iv 5mg/kg can eonvert BaCl_2-induced arrhythmia into sinus rhythm in rats, and can significantly increase the tolerant dose of aconitine to produce ventrieular fibrillation(VF) and cardiac arrest (CA) in rat... | |||
TN6559 | Isogambogic acid | ||
Isogambogic acid shows cytotoxic activiity against KB and drug-resistant KB-V1 cell lines. | |||
TN5153 | Torilin | MMP , ERK , IκB/IKK , p38 MAPK , NF-κB , Tyrosinase , Reductase , DNA/RNA Synthesis , JNK | |
Torilin is an inhibitor of testosterone 5 alpha-reductase, it (IC50 = 31.7 +/- 4.23 microM) shows a stronger inhibition of 5 alpha-reductase than alpha-linolenic acid (IC50 = 160.3 +/- 24.62 microM) but is weaker than fi... |
カタログ番号 | 製品名 | Species | Expression System |
---|---|---|---|
TMPY-02529 | VNN1 Protein, Mouse, Recombinant (His) | Mouse | HEK293 Cells |
VNN1 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 53.4 kDa and the accession number is Q9Z0K8. | |||
TMPY-06352 | ALDH1A3 Protein, Mouse, Recombinant (His) | Mouse | E. coli |
ALDH1A3 Protein, Mouse, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 56.94 kDa and the accession number is Q9JHW9. | |||
TMPY-04137 | ATP6V1F Protein, Human, Recombinant (GST) | Human | E. coli |
ATP6V1F encodes a component of vacuolar ATPase mediating acidification. The cDNA and the genomic sequences of ATP6V1F were cloned successfully for the first time from the Giant Panda (Ailuropoda melanoleuca) using revers... | |||
TMPY-02730 | VNN1 Protein, Mouse, Recombinant (hFc) | Mouse | HEK293 Cells |
VNN1 Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 79 kDa and the accession number is Q9Z0K8. | |||
TMPY-00891 | Neuropilin-1 Protein, Human, Recombinant (V179A, hFc) | Human | HEK293 Cells |
Neuropilin-1 Protein, Human, Recombinant (V179A, hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 96.5 kDa and the accession number is O14786-2. | |||
TMPY-01813 | ACRV1 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Acrosomal protein SP-1, also known as Acrosomal vesicle protein 1 and ACRV1, is a testis-specific, differentiation antigen, that arises within the acrosomal vesicle during spermatogenesis, and is associated with the a... | |||
TMPY-06398 | SARS-CoV-2 Spike S1+S2 Protein (E484K & F565L & D614G & V1176F, His) | SARS-CoV-2 | Baculovirus Insect Cells |
SARS-CoV-2 Spike S1+S2 Protein (E484K & F565L & D614G & V1176F, His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 134.35 kDa and the accession number is A0A6G7K2L4. | |||
TMPK-01505 | HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein, Human, MHC (His & Avi), Biotinylated | Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KD... | |||
TMPY-06159 | SARS-CoV-2 Spike S1+S2 Protein (L18F & T20N & P26S & D138Y & R190S & K417T & E484K & N501Y & D614G & H655Y & T1027I & V1176F, His) | SARS-CoV-2 | Baculovirus Insect Cells |
SARS-CoV-2 Spike S1+S2 Protein (L18F & T20N & P26S & D138Y & R190S & K417T & E484K & N501Y & D614G & H655Y & T1027I & V1176F, His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is ... | |||
TMPY-06399 | SARS-CoV-2 Spike S1 Protein (E484K & F565L & D614G & V1176F, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike S1 Protein (E484K & F565L & D614G & V1176F, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 76.37 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06420 | SARS-CoV-2 Spike S1 Protein (P26S & 69-70 deletion & V126A & Y144 deletion & 241-243 deletion & H245Y & S477N & E484K & D614G & P681H, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike S1 Protein (P26S & 69-70 deletion & V126A & Y144 deletion & 241-243 deletion & H245Y & S477N & E484K & D614G & P681H, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular wei... | |||
TMPH-02035 | ASPRV1 Protein, Human, Recombinant (His & Myc) | Human | E. coli |
ASPRV1 Protein, Human, Recombinant (His & Myc) is expressed in in vitro E. coli expression system. | |||
TMPJ-01100 | UBE2V1 Protein, Human, Recombinant (His) | Human | E. coli |
Ubiquitin-Conjugating Enzyme Variant 1a (UBE2V1) is a member of the Ubiquitin-conjugating (E2) enzyme family. The E2 catalytic core domain of UBE2V1 lacks an active site cysteine residue, rendering it catalytically inact... | |||
TMPK-00598 | Fc gamma RIIIA/CD16a (V176) Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 Cells |
The Human Fc gamma RIIIA/CD16a Protein is a receptor for the Fc region of IgG. Binds complexed or aggregated IgG and also monomeric IgG. Mediates antibody-dependent cellular cytotoxicity (ADCC) and other antibody-depende... | |||
TMPJ-00849 | ST2/IL-1 RL1 Protein, Mouse, Recombinant (V192A, hFc) | Mouse | HEK293 Cells |
ST2/IL-1 RL1 Protein, Mouse, Recombinant (V192A, hFc) is expressed in HEK293 mammalian cells with C-Fc tag. The predicted molecular weight is 90-110 KDa and the accession number is P14719-2. | |||
TMPH-02718 | Igkv12-41 Protein, Mouse, Recombinant (His & Myc) | Mouse | E. coli |
Igkv12-41 Protein, Mouse, Recombinant (His & Myc) is expressed in E. coli. | |||
TMPY-06429 | SARS-CoV-2 Spike S1+S2 Protein (P26S, 69-70 deletion & V126A & Y144 deletion & 241-243 deletion & H245Y & S477N & E484K & D614G & P681H & T1027I & D1118H, His) | SARS-CoV-2 | Baculovirus Insect Cells |
SARS-CoV-2 Spike S1+S2 Protein (P26S, 69-70 deletion & V126A & Y144 deletion & 241-243 deletion & H245Y & S477N & E484K & D614G & P681H & T1027I & D1118H, His) is expressed in Baculovirus insect cells with His tag. The p... | |||
TMPY-04622 | PF4V1 Protein, Human, Recombinant (mFc) | Human | HEK293 Cells |
PF4V1 Protein, Human, Recombinant (mFc) is expressed in HEK293 mammalian cells with mFc tag. The predicted molecular weight is 34.6 kDa and the accession number is P10720. | |||
TMPH-03068 | OV16 Protein, Onchocerca volvulus, Recombinant (His) | Onchocerca volvulus | E. coli |
OV16 Protein, Onchocerca volvulus, Recombinant (His) is expressed in E. coli. | |||
TMPH-03754 | NAV1 Protein, Human, Recombinant (His) | Human | E. coli |
May be involved in neuronal migration. | |||
TMPK-01504 | HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Tetramer Protein, Human, MHC (His & Avi) | Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KD... | |||
TMPK-01506 | HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein, Human, MHC (His & Avi) | Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KD... | |||
TMPH-00140 | IBV (strain V18/91) Nucleoprotein/NP Protein (His) | IBV | HEK293 Cells |
Packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an impo... | |||
TMPK-00599 | Fc gamma RIIIA/CD16a (V176) Domain 2 Protein, Human, Recombinant (mFc) | Human | HEK293 Cells |
Human Fc gamma RIIIA/CD16a Protein is a receptor for the Fc region of IgG. Binds complexed or aggregated IgG and also monomeric IgG. Mediates antibody-dependent cellular cytotoxicity (ADCC) and other antibody-dependent r... | |||
TMPK-00597 | Fc gamma RIIIA/CD16a (V176) Protein, Human, Recombinant (His & Avi) | Human | HEK293 Cells |
Human Fc gamma RIIIA/CD16a Protein is a receptor for the Fc region of IgG. Binds complexed or aggregated IgG and also monomeric IgG. Mediates antibody-dependent cellular cytotoxicity (ADCC) and other antibody-dependent r... |